This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories (ABT) slipped 2.09% to $82.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&amp;P 500 Index rising 0.19% to 7,412.84 and the Dow Jones Industrial Average rising 0.19% to 49,704.47.
This was the stock's second consecutive day of losses.
Abbott Laboratories closed 40.63% below its 52-week high of $139.06, which the company reached on June 24th.
The stock underperformed when compared to some of its competitors Monday, as Johnson &amp; Johnson (JNJ) rose 0.05% to $221.43, Pfizer Inc. (PFE) rose 0.51% to $25.81, and Merck &amp; Co. Inc. (MRK) fell 0.09% to $111.28.
Trading volume (16.2 M) eclipsed its 50-day average volume of 12.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled May 11, 2026.
This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
05-11-26 1636ET

Abbott Laboratories (ABT) shares fell 2.09% to $82.56 on Monday, marking its second consecutive day of losses, while the S&P 500 and Dow Jones both rose 0.19%. The stock is currently 40.63% below its 52-week high of $139.06. In comparison, competitors like Johnson & Johnson and Pfizer saw slight gains, while Merck experienced a minor decline. Trading volume for Abbott was 16.2 million, surpassing its 50-day average of 12.6 million.

MarketWatch Automated

Abbott Laboratories

iShares Global Healthcare

Health Care Select Sector SPDR

iShares US Pharma

SPDR S&P Health Equip

VG Health

iShares US Medical Devices

S&P 500

Dow Jones Industrial Average

Johnson & Johnson

Pfizer

Merck

Factset Research

Abbott Laboratories Stock Underperforms Monday When Compared To Competitors